切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Histone Demethylases - Dihydroorotate dehydrogenase - Insulin and Insulin-like Receptors - Carbonic Anhydrases

14件产品中的 1-10

页面
每页
清除全部
  1. SP2509
    B4894 SP2509
    Target: Histone Demethylases
    Summary: 新型LSD1拮抗剂
      ≥19.45 mg/mL
      insoluble in H2O
  2. Dorzolamide
    B1279 Dorzolamide
    中文名: 多佐胺
    Target: Carbonic Anhydrases
    Summary: 碳酸酐酶抑制剂
      Soluble in DMSO
  3. Teriflunomide
    B1850 Teriflunomide
    中文名: 特立氟胺
    Target: Dihydroorotate dehydrogenase
    Summary: 二氢乳清酸脱氢酶的抑制剂
      ≥13.5 mg/mL
      insoluble in H2O
  4. Chlorothiazide
    A8397 Chlorothiazide
    中文名: 氯噻嗪
    Target: Carbonic Anhydrases
    Summary: 碳酸酐酶抑制剂
      ≥14.85 mg/mL
      insoluble in H2O
  5. Methyocarbamol
    A8473 Methyocarbamol
    中文名: 美索巴莫
    Target: Carbonic Anhydrases
    Summary: 碳酸酐酶抑制剂
      ≥15.65 mg/mL
      ≥7.7 mg/mL
  6. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: ATP竞争性IGF-IR/IR/ALK抑制剂
      ≥26.65 mg/mL
      insoluble in H2O
  7. Zonisamide
    A5354 Zonisamide
    中文名: 唑尼沙胺
    Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Carbonic Anhydrases|Calcium-Activated Potassium (KCa) Channels
    Summary: 抗惊厥和机械效应的抗癫痫药
      ≥8.35 mg/mL
      insoluble in H2O
  8. GSK1904529A
    A1302 GSK1904529A
    Target: Insulin and Insulin-like Receptors
    Summary: IGF-1R/IR 选择性抑制剂
      ≥42.6 mg/mL
      insoluble in H2O
  9. BMS-754807
    A1185 BMS-754807
    Target: Insulin and Insulin-like Receptors
    Summary: 有效的、选择性的IGF-1R和InsR抑制剂
      ≥23.05 mg/mL
      insoluble in H2O
  10. MK 0893
    A3608 MK 0893
    Target: Insulin and Insulin-like Receptors|Glucagon Receptors
    Summary: 胰高血糖素受体/ IGF-1R拮抗剂
      ≥24.05 mg/mL
      insoluble in H2O

14件产品中的 1-10

页面
每页